A Smoke-Free Home Intervention in Tribal Communities

Part of paid clinical trials in Atlanta, Georgia.

Sponsor
Emory University
Study ID
NCT06583148
Status
Recruiting

Conditions

  • Tobacco-Related Carcinoma

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Accepted

Interventions

  • Best Practice — OTHER
    Receive usual care
  • Smoking Cessation Intervention — BEHAVIORAL
    Receive the smoke-free home program
  • Survey Administration — OTHER
    Ancillary studies

Study Details

This clinical trial evaluates a smoke-free home intervention for reducing exposure to secondhand smoke from commercial tobacco in homes of participants who live in rural tribal communities. Smoke-free homes are an innovative and relatively untapped strategy for cancer prevention in rural tribal communities. Smoke-free policies, including those that target homes, can reduce exposure to secondhand smoke and support smoking cessation. Rural and racial/ethnic inequities intersect to increase tobacco-related harms among Indigenous populations. A smoke-free home program may improve the health of the household as well as impact smoking behavior among the family unit by reducing secondhand smoke exposure.

Key Dates

Start date
Nov 15, 2024
Status verified
Dec 2025
Primary completion
Jan 31, 2028
Completion
Jan 31, 2029

Study Design

Enrollment
575 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION

Arms

  • Experimental: Group I (smoke-free home program)
    Participants receive the smoke-free home program, consisting of mailed educational information about smoke-free homes at enrollment and in weeks 4 and 6, and attend one coaching call in week 2.
  • Active Comparator: Group II (waitlist control)
    Participants receive usual care on study. Participants may optionally receive the smoke-free home program following the 6 months follow-up.

Primary Outcome Measure

Self-Reported Smoke-Free Home [ Time Frame: At 3 and 6 months ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Emory University Hospital/Winship Cancer InstituteAtlantaGeorgia30322
Michelle Kegler, DrPH, MPH
404-712-9957
Michelle Kegler, DrPH, MPH (PRINCIPAL_INVESTIGATOR)

Find similar trials in Atlanta, GA

Related Studies